Inhibition of glucose-stimulated activation of extracellular signal-regulated protein kinases 1 and 2 by epinephrine in pancreatic β-cells

Tara Beers Gibson, Michael C. Lawrence, Craig J. Gibson, Colleen A. Vanderbilt, Kathleen McGlynn, Don Arnette, Wei Chen, Julie Collins, Bashoo Naziruddin, Marlon F. Levy, Barbara E. Ehrlich, Melanie H. Cobb

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Glucose sensing is essential for the ability of pancreatic β-cells to produce insulin in sufficient quantities to maintain blood glucose within the normal range. Stress causes the release of adrenergic hormones that increase circulating glucose by promoting glucose production and inhibiting insulin release. We have shown that extracellular signal-regulated kinases 1 and 2 (ERK1/2) are responsive to glucose in pancreatic β-cells and that glucose activates ERK1/2 by mechanisms independent of insulin. Here we show that glucose-induced activation of ERK1/2 is inhibited by epinephrine through the α2-adrenergic receptor. Epinephrine and the selective 2-adrenergic agonist UK14304 reduced insulin secretion and glucose-stimulated ERK1/2 activation in a pertussis toxin-sensitive manner, implicating the subunit of a Gi family member α2-adrenergic agonists also reduced stimulation of ERK1/2 by glucagon-like peptide 1 and KCl, but not by phorbol ester or nerve growth factor. Our findings suggest that 2-adrenergic agonists act via a Gi family member on early steps in ERK1/2 activation, supporting the idea that ERK1/2 are regulated in a manner that reflects insulin demand.

Original languageEnglish (US)
Pages (from-to)1066-1073
Number of pages8
JournalDiabetes
Volume55
Issue number4
DOIs
StatePublished - 2006

Fingerprint

Mitogen-Activated Protein Kinase 3
Mitogen-Activated Protein Kinase 1
Protein Kinases
Epinephrine
Glucose
Adrenergic Agonists
Insulin
Glucagon-Like Peptide 1
Aptitude
Pertussis Toxin
Phorbol Esters
Nerve Growth Factor
Inhibition (Psychology)
Adrenergic Agents
Adrenergic Receptors
Blood Glucose
Reference Values
Hormones

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Inhibition of glucose-stimulated activation of extracellular signal-regulated protein kinases 1 and 2 by epinephrine in pancreatic β-cells. / Gibson, Tara Beers; Lawrence, Michael C.; Gibson, Craig J.; Vanderbilt, Colleen A.; McGlynn, Kathleen; Arnette, Don; Chen, Wei; Collins, Julie; Naziruddin, Bashoo; Levy, Marlon F.; Ehrlich, Barbara E.; Cobb, Melanie H.

In: Diabetes, Vol. 55, No. 4, 2006, p. 1066-1073.

Research output: Contribution to journalArticle

Gibson, TB, Lawrence, MC, Gibson, CJ, Vanderbilt, CA, McGlynn, K, Arnette, D, Chen, W, Collins, J, Naziruddin, B, Levy, MF, Ehrlich, BE & Cobb, MH 2006, 'Inhibition of glucose-stimulated activation of extracellular signal-regulated protein kinases 1 and 2 by epinephrine in pancreatic β-cells', Diabetes, vol. 55, no. 4, pp. 1066-1073. https://doi.org/10.2337/diabetes.55.04.06.db05-1266
Gibson, Tara Beers ; Lawrence, Michael C. ; Gibson, Craig J. ; Vanderbilt, Colleen A. ; McGlynn, Kathleen ; Arnette, Don ; Chen, Wei ; Collins, Julie ; Naziruddin, Bashoo ; Levy, Marlon F. ; Ehrlich, Barbara E. ; Cobb, Melanie H. / Inhibition of glucose-stimulated activation of extracellular signal-regulated protein kinases 1 and 2 by epinephrine in pancreatic β-cells. In: Diabetes. 2006 ; Vol. 55, No. 4. pp. 1066-1073.
@article{c728d9c9f8e14ca9b410bfdd3f650b6b,
title = "Inhibition of glucose-stimulated activation of extracellular signal-regulated protein kinases 1 and 2 by epinephrine in pancreatic β-cells",
abstract = "Glucose sensing is essential for the ability of pancreatic β-cells to produce insulin in sufficient quantities to maintain blood glucose within the normal range. Stress causes the release of adrenergic hormones that increase circulating glucose by promoting glucose production and inhibiting insulin release. We have shown that extracellular signal-regulated kinases 1 and 2 (ERK1/2) are responsive to glucose in pancreatic β-cells and that glucose activates ERK1/2 by mechanisms independent of insulin. Here we show that glucose-induced activation of ERK1/2 is inhibited by epinephrine through the α2-adrenergic receptor. Epinephrine and the selective 2-adrenergic agonist UK14304 reduced insulin secretion and glucose-stimulated ERK1/2 activation in a pertussis toxin-sensitive manner, implicating the subunit of a Gi family member α2-adrenergic agonists also reduced stimulation of ERK1/2 by glucagon-like peptide 1 and KCl, but not by phorbol ester or nerve growth factor. Our findings suggest that 2-adrenergic agonists act via a Gi family member on early steps in ERK1/2 activation, supporting the idea that ERK1/2 are regulated in a manner that reflects insulin demand.",
author = "Gibson, {Tara Beers} and Lawrence, {Michael C.} and Gibson, {Craig J.} and Vanderbilt, {Colleen A.} and Kathleen McGlynn and Don Arnette and Wei Chen and Julie Collins and Bashoo Naziruddin and Levy, {Marlon F.} and Ehrlich, {Barbara E.} and Cobb, {Melanie H.}",
year = "2006",
doi = "10.2337/diabetes.55.04.06.db05-1266",
language = "English (US)",
volume = "55",
pages = "1066--1073",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "4",

}

TY - JOUR

T1 - Inhibition of glucose-stimulated activation of extracellular signal-regulated protein kinases 1 and 2 by epinephrine in pancreatic β-cells

AU - Gibson, Tara Beers

AU - Lawrence, Michael C.

AU - Gibson, Craig J.

AU - Vanderbilt, Colleen A.

AU - McGlynn, Kathleen

AU - Arnette, Don

AU - Chen, Wei

AU - Collins, Julie

AU - Naziruddin, Bashoo

AU - Levy, Marlon F.

AU - Ehrlich, Barbara E.

AU - Cobb, Melanie H.

PY - 2006

Y1 - 2006

N2 - Glucose sensing is essential for the ability of pancreatic β-cells to produce insulin in sufficient quantities to maintain blood glucose within the normal range. Stress causes the release of adrenergic hormones that increase circulating glucose by promoting glucose production and inhibiting insulin release. We have shown that extracellular signal-regulated kinases 1 and 2 (ERK1/2) are responsive to glucose in pancreatic β-cells and that glucose activates ERK1/2 by mechanisms independent of insulin. Here we show that glucose-induced activation of ERK1/2 is inhibited by epinephrine through the α2-adrenergic receptor. Epinephrine and the selective 2-adrenergic agonist UK14304 reduced insulin secretion and glucose-stimulated ERK1/2 activation in a pertussis toxin-sensitive manner, implicating the subunit of a Gi family member α2-adrenergic agonists also reduced stimulation of ERK1/2 by glucagon-like peptide 1 and KCl, but not by phorbol ester or nerve growth factor. Our findings suggest that 2-adrenergic agonists act via a Gi family member on early steps in ERK1/2 activation, supporting the idea that ERK1/2 are regulated in a manner that reflects insulin demand.

AB - Glucose sensing is essential for the ability of pancreatic β-cells to produce insulin in sufficient quantities to maintain blood glucose within the normal range. Stress causes the release of adrenergic hormones that increase circulating glucose by promoting glucose production and inhibiting insulin release. We have shown that extracellular signal-regulated kinases 1 and 2 (ERK1/2) are responsive to glucose in pancreatic β-cells and that glucose activates ERK1/2 by mechanisms independent of insulin. Here we show that glucose-induced activation of ERK1/2 is inhibited by epinephrine through the α2-adrenergic receptor. Epinephrine and the selective 2-adrenergic agonist UK14304 reduced insulin secretion and glucose-stimulated ERK1/2 activation in a pertussis toxin-sensitive manner, implicating the subunit of a Gi family member α2-adrenergic agonists also reduced stimulation of ERK1/2 by glucagon-like peptide 1 and KCl, but not by phorbol ester or nerve growth factor. Our findings suggest that 2-adrenergic agonists act via a Gi family member on early steps in ERK1/2 activation, supporting the idea that ERK1/2 are regulated in a manner that reflects insulin demand.

UR - http://www.scopus.com/inward/record.url?scp=33745325250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745325250&partnerID=8YFLogxK

U2 - 10.2337/diabetes.55.04.06.db05-1266

DO - 10.2337/diabetes.55.04.06.db05-1266

M3 - Article

C2 - 16567530

AN - SCOPUS:33745325250

VL - 55

SP - 1066

EP - 1073

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 4

ER -